Skip to main content
Clinical Trials/NCT05400356
NCT05400356
Recruiting
N/A

Dynamics of Immune Map and Outcomes After On-pump Cardiac Surgery: Protocol for a Prospective Cohort Study

West China Hospital1 site in 1 country120 target enrollmentJune 1, 2022

Overview

Phase
N/A
Intervention
Not specified
Conditions
On-pump Valve Surgery or CABG
Sponsor
West China Hospital
Enrollment
120
Locations
1
Primary Endpoint
composite outcome
Status
Recruiting
Last Updated
3 years ago

Overview

Brief Summary

Although systemic inflammatory response induced by cardiopulmonary bypass is believed as one of main reasons for these adverse events, the involved mechanism is still unclear.This cohort study would include patients undergoing on-pump valve surgery or CABG. By detecting the changes of immune cell expression profile and inflammatory related substances in blood, the spatiotemporal change curve of immune function of patients is drawn for avoiding or treating adverse events.

Registry
clinicaltrials.gov
Start Date
June 1, 2022
End Date
March 31, 2023
Last Updated
3 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Lei Du

37#,Guoxue Road ,Chengdu, Sichuan Province, China

West China Hospital

Eligibility Criteria

Inclusion Criteria

  • (1) participants aged over 18 years; (2) Participants who scheduled for valve replacement or valvuloplasty, coronary artery bypass under CPB.

Exclusion Criteria

  • (1) participant with a cognitive or mental disorder who is unable to sign an informed consent form; (2) suffering from basic immune system and blood system diseases; (3) pregnancy; (4) preoperative radiotherapy and chemotherapy; (5) receive immunosuppressive drugs within six months;(6) Expected survival time less than 2 years;(7) participated in other intervention clinical trials within 30 days before operation.

Outcomes

Primary Outcomes

composite outcome

Time Frame: From the beginning of surgery to 30 days after surgery or to discharge from hospital

the incidence of vital organ injury, which is defined as a composite measure, including postoperative death, vital organ dysfunction, and mechanical ventilation duration greater than 24 hours. And the vital organ dysfunction includes new kidney injury, long-term low cardiac output, severe liver function injury and neurological function injury.

Secondary Outcomes

  • Infection(From the beginning of surgery to 30 days after surgery or to discharge from hospital])
  • Acute lung injury(From the beginning of surgery to 30 days after surgery or to discharge from hospital])
  • MACCE(From the beginning of surgery to 30 days after surgery or to discharge from hospital])
  • Gastrointestinal complications(From the beginning of surgery to 30 days after surgery or to discharge from hospital)

Study Sites (1)

Loading locations...

Similar Trials